Adverum Biotechnologies
ADVM
ADVM
61 hedge funds and large institutions have $237M invested in Adverum Biotechnologies in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
87% less call options, than puts
Call options by funds: $390K | Put options by funds: $2.98M
Holders
61
Holding in Top 10
2
Calls
$390K
Puts
$2.98M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$21.2M | |
| 3 | +$21.2M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$15.1M |
| 5 |
VA
VR Adviser
New York
|
+$14.7M |
Top Sellers
| 1 | -$6.62M | |
| 2 | -$4.85M | |
| 3 | -$3.74M | |
| 4 |
Goldman Sachs
New York
|
-$3.43M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.19M |